1. Home
  2. SCLX vs CNVS Comparison

SCLX vs CNVS Comparison

Compare SCLX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.30

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.48

Market Cap

54.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
CNVS
Founded
2011
2000
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
54.7M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SCLX
CNVS
Price
$6.30
$2.48
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
97.8K
137.7K
Earning Date
04-10-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.99
EPS
N/A
N/A
Revenue
N/A
$78,181,000.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
$84.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.13
52 Week Low
$4.20
$1.77
52 Week High
$34.27
$7.39

Technical Indicators

Market Signals
Indicator
SCLX
CNVS
Relative Strength Index (RSI) 41.26 47.64
Support Level $6.20 $2.31
Resistance Level $7.77 $2.56
Average True Range (ATR) 0.77 0.12
MACD -0.20 -0.01
Stochastic Oscillator 12.64 24.24

Price Performance

Historical Comparison
SCLX
CNVS

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

Share on Social Networks: